Literature DB >> 10719156

D(1) receptors in prefrontal cells and circuits.

P S Goldman-Rakic1, E C Muly, G V Williams.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10719156     DOI： 10.1016/s0165-0173(99)00045-4

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


× No keyword cloud information.
  243 in total

1.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Authors:  Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

3.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.

Authors:  B Liss; O Franz; S Sewing; R Bruns; H Neuhoff; J Roeper
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

5.  Methamphetamine blunts Ca(2+) currents and excitatory synaptic transmission through D1/5 receptor-mediated mechanisms in the mouse medial prefrontal cortex.

Authors:  Betina González; Celeste Rivero-Echeto; Javier A Muñiz; Jean Lud Cadet; Edgar García-Rill; Francisco J Urbano; Verónica Bisagno
Journal:  Addict Biol       Date:  2015-04-14       Impact factor: 4.280

6.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

7.  Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence.

Authors:  D Tomasi; R Z Goldstein; F Telang; T Maloney; N Alia-Klein; E C Caparelli; N D Volkow
Journal:  Brain Res       Date:  2007-08-10       Impact factor: 3.252

8.  D1, but not D2, receptor blockade within the infralimbic and medial orbitofrontal cortex impairs cocaine seeking in a region-specific manner.

Authors:  Caitlin V Cosme; Andrea L Gutman; Wensday R Worth; Ryan T LaLumiere
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

9.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

10.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.